# Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01)

Study · id `cardio:ct-nct03195023` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03195023](<https://clinicaltrials.gov/study/NCT03195023>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03195023

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 106 participants.

## Technical summary

Registry record NCT03195023. Randomized; no masking; primary purpose treatment. Start 2015-06 (registry gives no type); primary completion 2019-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 106 participants (planned count; ClinicalTrials.gov record NCT03195023, source copy `cardio:ctgov-nct03195023-2019-02-22`, retrieved 2026-10-26)
- Start date: 2015-06 (registry gives no type) (ClinicalTrials.gov record NCT03195023, source copy `cardio:ctgov-nct03195023-2019-02-22`, retrieved 2026-10-26)
- Primary completion: 2019-12 (anticipated) (ClinicalTrials.gov record NCT03195023, source copy `cardio:ctgov-nct03195023-2019-02-22`, retrieved 2026-10-26)
- Completion: 2022-12 (anticipated) (ClinicalTrials.gov record NCT03195023, source copy `cardio:ctgov-nct03195023-2019-02-22`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT03195023, source copy `cardio:ctgov-nct03195023-2019-02-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03195023-2019-02-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01)
- Acronym: PROERCAN01
- Condition: Renal Insufficiency, Chronic
- Condition: Proteinuria
- Intervention (Drug): Lisinopril
- Intervention (Drug): Amlodipine
- Lead sponsor: Hospital General Universitario Gregorio Marañon
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry intervention name matches this record: Lisinopril (`cardio:lisinopril`)
- Registry intervention name matches this record: Amlodipine (`cardio:amlodipine`)
- Registry lists this organization as the lead sponsor: Hospital General Universitario Gregorio Marañon (`cardio:org-hospital-general-universitario-gregorio-maranon`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Renin-angiotensin-aldosterone system blockers effect in chronic kidney disease progression in hypertensive elderly patients without proteinuria: PROERCAN trial (`cardio:pubmed-38508877`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: e867ff4d0389b2d4087ff0d4f09a26c048223c09d95e19d346181c046133cdcc
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
